Dr. Elise M. Herro, MD

Dr. Herro practices at Surgery Center at the American Skin Institute in Sherman Oaks, California.

Dr. Herro's NPI, 1104053743, was assigned on June 21, 2009. Dr. Herro graduated from The University of Arizona College of Medicine, Phoenix in 2009. Dr. Herro holds California license 114480.

Dr. Herro's primary practice is Surgery Center at the American Skin Institute, at 4836 Van Nuys Blvd, Sherman Oaks, CA 91403. The practice phone is (818) 907-7546.

Dr. Herro's primary practice is Surgery Center at the American Skin Institute in Sherman Oaks, California. The medical group on file is American Skin Institute. Dmand AI also links Dr. Herro to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Herro practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Herro's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Herro is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Herro's licenses on file in 3 states: California, Arizona and Illinois.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, itchy rashes, minor injury to a limb, psoriasis and rash among the conditions Dr. Herro treats.

CMS data shows 1,527 Medicare services from Dr. Herro across 10 procedure codes in 2024, for 196 Medicare patients. Medicare paid $70,418 for them. Every service was in an office.

CMS counts 196 Medicare patients who saw Dr. Herro in 2024. The largest group is 65 to 74, with 95 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 11% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Herro's median patient age at 67, with 64% women.

In 2024, Dr. Herro wrote 341 Medicare Part D claims for 118 patients. 93% of them were for generic drugs. CMS names the drug for 257 of them, across 10 drugs with 11 or more claims each, at $73,997 in total drug cost. In 2023, CMS named 243 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Herro for performance year 2024, reported as part of a group. Dr. Herro accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 463 procedures of removal of skin lesions by Dr. Herro, more than 86% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 24 papers to Dr. Herro, published from 2009 to 2018. 2011 was the busiest year, with 2. The most frequent topics are Dermatitis, Allergic Contact, Patch Tests and Allergens. Dr. Herro has published most often in Dermatitis. Dr. Herro's most frequent co-authors are Catalina Matiz, MD, Sheila Fallon Friedlander, MD and Shehla Admani, MD.

CMS Open Payments shows 71 general payments to Dr. Herro from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $661.

Dr. Herro graduated from The University of Arizona College of Medicine, Phoenix in 2009.

Dr. Herro is in network with 13 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.